("Aurrigo", "the Group" or the "Company")
Director/PDMR Shareholding
Following this purchase,
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||
|
|
|
||
|
a) |
|
|
|
|
2 |
Reason for the notification |
||
|
a) |
Position/status
|
Chief Financial Officer
|
|
|
b) |
Initial notification /Amendment |
Initial Notification
|
|
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||
|
a)
|
|
|
|
|
b)
|
LEI
|
213800FPH71B7UWC7104 |
|
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares of
ISIN: GB00BNG73286
|
|
|
b)
|
Nature of the transaction
|
Purchase of Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s) |
Volume(s) |
|
|
4,632 |
||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/a
|
|
|
e)
|
Date of the transaction
|
|
|
|
f)
|
Place of the transaction
|
|
|
Contacts:
|
|
+44 (0)2476 635818 |
|
Canaccord Genuity (Nominated Adviser and Sole Broker) |
+44 (0)20 7523 8000
|
|
Alma
|
+44(0)20 3405 0205 |
|
Cucumber PR |
+44 (0)78 1260 0271 |
Notes to Editors:
The Group's proprietary, award-winning autonomous technology and secure management system is supporting some of the world's leading airports. Customers choose to partner with Aurrigo to transform their baggage and cargo handling operations, improving safety, operational efficiencies and meeting sustainability targets, while navigating growing passenger volumes, rising costs and increasing labour shortages.
Headquartered in
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the